We use cookies to ensure that we give you the best experience on our website.
By continuing to browse this site, you are agreeing to our use of cookies as set out in our cookie notice.

COOKIES POLICY CONTINUE
This site is intended for US healthcare professionals.
Important Safety Information Full Prescribing Information Patient Site
GETTING STARTED STAY CONNECTED
VPRIV (velaglucerase alfa) for injection

VPRIV® (velaglucerase alfa) for injection is indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease.

VPRIV® (velaglucerase alfa) for injection is indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease.

  • RECOGNIZING TYPE 1
    GAUCHER DISEASE
    • Prevalence
    • Common Symptoms
    • Diagnosis Challenges
  • VPRIV, an ERT
    • How ERT Works
    • How VPRIV Works
  • Clinical Profile &
    Patient Population
    • Clinical Trial Program Overview
    • Treatment-Naïve Clinical Trials
    • - Pediatric Subset Pediatric Subset
    • - Additional Data Analysis Additional Data Analysis
    • Treatment-Experienced Clinical Trials
    • VPRIV Patient Population
    • VPRIV
      Patient Profiles
  • Safety &
    Tolerability
    • Safety Profile
    • Tolerability Profile
  • Dosing &
    Administration
    • Dosing Calculation & Patient Assessment
    • VPRIV Preparation & Handling
    • VPRIV Administration
  • Support &
    Resources
    • Takeda Support Programs
    • Resources
  • Contact A Rep

ARE YOU A US HEALTHCARE PROFESSIONAL?

You are being directed to hcp.vpriv.com. This website is intended to provide
information for healthcare professionals residing in the US only.

I am an HCP residing in the US.
Please direct me to hcp.vpriv.com

I am not an HCP residing in the US.
Please direct me to the VPRIV patient site.

UNSUBSCRIBE

To unsubscribe from future communications, please fill in the required fields, and click submit.

One or more required fields are invalid. Please review and submit this form again.

*Required Field

UNSUBSCRIBED!

You have successfully unsubscribed.

STAY CONNECTED!

Fill in the required fields to stay up to date with news and announcements about VPRIV.

*Required Field

*By checking this box and clicking “Submit,” you certify that you are at least 18 years old, a US resident, and you are opting to receive information about VPRIV and other information from Takeda. You will be able to opt out of these communications using the unsubscribe feature.

Takeda respects your personal information. All personal and/or medical information you have provided will be kept confidential and will not be used or distributed to anyone for any purpose other than what is explained in our Privacy Notice Statement. We encourage you to read our Privacy Notice Statement. This consent will be in effect until such a time as you opt out of the program.

One or more required fields are invalid. Please review and submit this form again.

STAY CONNECTED!

THANK YOU!

You have been successfully signed up to
receive communications from Takeda

Click here to unsubscribe.

YOU ARE ABOUT TO LEAVE THIS SITE.

You are now being taken to an external website that is not under the control
of Takeda. We have no control over the nature, content, and availability of
those sites. The inclusion of any links does not necessarily imply a
recommendation or endorsement of the views expressed within them.

Do you wish to continue and leave this website?

Takeda
  • CONTACT US
  • PRIVACY POLICY
  • TERMS OF USE
  • COOKIES POLICY
  • UNSUBSCRIBE
  • SITE MAP
For more information, contact Takeda at 1-877-TAKEDA-7
(1-877-825-3327), or by e-mail at medinfous@takeda.com.
  • CONTACT US
  • PRIVACY POLICY
  • TERMS OF USE
  • COOKIES POLICY
  • UNSUBSCRIBE
  • SITE MAP

©2021 Takeda Pharmaceuticals U.S.A., Inc. 300 Shire Way, Lexington, MA 02421. 1-877-TAKEDA-7 (1-877-825-3327). All rights reserved. VPRIV and the VPRIV logo are registered trademarks of Shire Human Genetic Therapies, Inc., a Takeda company. OnePath, the OnePath logo, and PreppedAhead are trademarks or registered trademarks of Takeda or its affiliates. TAKEDA and the TAKEDA logo are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited. US-VEL-0425v1.0 10/21

All images used on this website do not portray actual patients.

All content of this website, including text, images, graphics, sound files, and their arrangement, belongs to Takeda and is protected by international copyright laws. All other intellectual property rights are reserved. Except to the extent provided for herein, the content may not be copied for commercial use or distribution, nor may these objects be downloaded, modified, or posted to other sites. This site is intended solely for US residents and is governed solely by US laws and government regulations. Please see our online privacy policy for more information. While Takeda US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Takeda makes no warranties or representations as to its accuracy. Takeda assumes no liability for any errors or omissions in the content of the site.

Takeda

CONTACT A REP

THANK YOU!

Thank you for your interest! A member of staff will
reach out to you soon to schedule a meeting with you.

up arrow